- €2.09bn
- €5.09bn
- $3.70bn
- 54
- 87
- 98
- 96
Annual income statement for VEON, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8,863 | 7,291 | 3,850 | 3,755 | 3,698 |
| Cost of Revenue | |||||
| Gross Profit | 6,830 | 5,579 | 3,366 | 3,279 | 3,257 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6,844 | 6,780 | 2,827 | 2,592 | 2,817 |
| Operating Profit | 2,019 | 511 | 1,023 | 1,163 | 881 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,181 | -82 | 464 | 802 | 559 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 683 | -395 | 120 | 733 | 380 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 621 | -349 | 674 | -162 | -2,528 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 621 | -349 | 674 | -162 | -2,528 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.405 | 0.089 | 0.003 | 0.285 | 0.173 |
| Dividends per Share |